General practitioner Practice manager GP practices

Last updated:

Guidance for GPs, dispensing doctors and community pharmacists

Best practice for ensuring the efficient supply of medicines to patients

This joint statement on managing the supply chain of medicines is relevant to prescribers, dispensing doctors, pharmacists, manufacturers and wholesalers.

Read the statement

Guidance on proposed changes to the Human Medicines Regulation 2012 to ensure the continuity of supply of medicines (including in a no-deal EU exit).

Read the guidance

 

Prescription direction - maintaining good practice

A joint statement from the BMA and Pharmaceutical Services Negotiating Committee on prescription direction which illustrates activities to avoid in order to maintain good practice.

Read the joint statement

 

The community pharmacy - a guide for GPs and practice staff

This guide covers key areas such as funding arrangements, impact of prescribing policies, and clinical and administrative functions, and will assist in developing more effective working relationships and in turn, improve primary care services for patients.

Read the guidance [PDF]

 

Guidance for the implementation of repeat dispensing

This joint guidance explains what repeat dispensing is, how suitable patients might be identified and the potential benefits. It also gives the tops ten tips for successful implementation, as suggested by GPs, practice managers and pharmacists.

Read the guidance

The Pharmaceutical Services Negotiating Committee has also published some other guidance, including template letters for repeat dispensing.

Access the PSNC guidance

 

Community pharmacy advanced services

Pharmaceutical services negotiating committee (PSNC) has published a briefing to provide information for GP practices about advanced services provided by community pharmacies in England, including the medicine use reviews and the new medicines service. 

Read the guidance

 

Association of British Pharmaceutical Industries (ABPI) code of practice

A key change to the ABPI Code of Practice came into effect in 2012. Pharmaceutical companies now have to declare total amounts paid to health professionals for services such as speaker fees and participation in advisory boards.

Read the guidance